Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Dr. Dehlin, et al reply.

Dehlin M, Landgren AJ, Bergsten U, Jacobsson LTH.

J Rheumatol. 2019 Jul 15. pii: jrheum.190552. doi: 10.3899/jrheum.190552. [Epub ahead of print]

PMID:
31308204
2.

Low specificity but high sensitivity of inflammatory back pain criteria in rheumatology settings in Europe: confirmation of findings from a German cohort study.

de Hooge M, van Gaalen FA, Renson T, De Craemer AS, van de Sande MG, Ramonda R, Fagerli KM, Jacobsson LTH, van der Heijde D, Elewaut D, Van den Bosch F.

Ann Rheum Dis. 2019 Jul 13. pii: annrheumdis-2019-215742. doi: 10.1136/annrheumdis-2019-215742. [Epub ahead of print] No abstract available.

PMID:
31302595
3.
4.

Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndrome.

Olsson P, Bodewes ILA, Nilsson AM, Turesson C, Jacobsson LTH, Theander E, Versnel MA, Mandl T.

Rheumatol Int. 2019 Sep;39(9):1575-1584. doi: 10.1007/s00296-019-04335-3. Epub 2019 May 28.

PMID:
31139950
5.

Urate and risk of Alzheimer's disease and vascular dementia: A population-based study.

Scheepers LEJM, Jacobsson LTH, Kern S, Johansson L, Dehlin M, Skoog I.

Alzheimers Dement. 2019 Jun;15(6):754-763. doi: 10.1016/j.jalz.2019.01.014. Epub 2019 May 2.

PMID:
31056343
6.

The Validity of Gout Diagnosis in Primary Care: Results from a Patient Survey.

Dehlin M, Landgren AJ, Bergsten U, Jacobsson LTH.

J Rheumatol. 2019 Apr 1. pii: jrheum.180989. doi: 10.3899/jrheum.180989. [Epub ahead of print]

PMID:
30936288
7.

Factors related to health-related quality of life in ankylosing spondylitis, overall and stratified by sex.

Law L, Beckman Rehnman J, Deminger A, Klingberg E, Jacobsson LTH, Forsblad-d'Elia H.

Arthritis Res Ther. 2018 Dec 27;20(1):284. doi: 10.1186/s13075-018-1784-8.

8.

Are gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data from the SPondyloArthritis Caught Early cohort.

Ortolan A, van Lunteren M, Ramiro S, Ramonda R, Landewé RBM, Dagfinrud H, Jacobsson LTH, van der Heijde D, van Gaalen FA.

Arthritis Res Ther. 2018 Oct 1;20(1):218. doi: 10.1186/s13075-018-1705-x.

9.

Correction to: Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy.

Drivelegka P, Sigurdardottir V, Svärd A, Jacobsson LTH, Dehlin M.

Arthritis Res Ther. 2018 Sep 10;20(1):206. doi: 10.1186/s13075-018-1700-2.

10.

Effects of Treatment with Adalimumab on Blood Lipid Levels and Atherosclerosis in Patients with Rheumatoid Arthritis.

Bergström U, Jovinge S, Persson J, Jacobsson LTH, Turesson C.

Curr Ther Res Clin Exp. 2018 Jul 23;89:1-6. doi: 10.1016/j.curtheres.2018.07.001. eCollection 2018.

11.

A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis.

Deminger A, Klingberg E, Geijer M, Göthlin J, Hedberg M, Rehnberg E, Carlsten H, Jacobsson LT, Forsblad-d'Elia H.

Arthritis Res Ther. 2018 Aug 3;20(1):162. doi: 10.1186/s13075-018-1665-1.

12.

Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy.

Drivelegka P, Sigurdardottir V, Svärd A, Jacobsson LTH, Dehlin M.

Arthritis Res Ther. 2018 Jun 1;20(1):108. doi: 10.1186/s13075-018-1596-x. Erratum in: Arthritis Res Ther. 2018 Sep 10;20(1):206.

13.

Smoking, disease characteristics and serum cytokine levels in patients with primary Sjögren's syndrome.

Olsson P, Skogstrand K, Nilsson A, Turesson C, Jacobsson LTH, Theander E, Houen G, Mandl T.

Rheumatol Int. 2018 Aug;38(8):1503-1510. doi: 10.1007/s00296-018-4063-8. Epub 2018 May 30.

14.

Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis.

Rydell E, Forslind K, Nilsson JÅ, Jacobsson LTH, Turesson C.

Arthritis Res Ther. 2018 May 2;20(1):82. doi: 10.1186/s13075-018-1575-2.

15.

Imaging of the sacroiliac joints is important for diagnosing early axial spondyloarthritis but not all-decisive.

Ez-Zaitouni Z, Landewé R, van Lunteren M, Bakker PA, Fagerli KM, Ramonda R, Jacobsson LTH, van der Heijde D, van Gaalen FA.

Rheumatology (Oxford). 2018 Mar 20. doi: 10.1093/rheumatology/key035. [Epub ahead of print]

PMID:
29579265
16.

Trends in Gout Hospitalization in Sweden.

Dehlin M, Jacobsson LTH.

J Rheumatol. 2018 Jan;45(1):145-146. doi: 10.3899/jrheum.170381. No abstract available.

PMID:
29292318
17.

Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a register-based study from Sweden.

Bengtsson K, Forsblad-d'Elia H, Lie E, Klingberg E, Dehlin M, Exarchou S, Lindström U, Askling J, Jacobsson LTH.

Ann Rheum Dis. 2018 Apr;77(4):541-548. doi: 10.1136/annrheumdis-2017-212189. Epub 2017 Dec 19.

PMID:
29259045
18.

Which measuring site in ankylosing spondylitis is best to detect bone loss and what predicts the decline: results from a 5-year prospective study.

Deminger A, Klingberg E, Lorentzon M, Geijer M, Göthlin J, Hedberg M, Rehnberg E, Carlsten H, Jacobsson LT, Forsblad-d'Elia H.

Arthritis Res Ther. 2017 Dec 8;19(1):273. doi: 10.1186/s13075-017-1480-0.

19.

Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population-Based Cohort Study.

de Vries MK, Arkema EV, Jonsson J, Bruchfeld J, Jacobsson LTH, Askling J; ARTIS Study Group.

Arthritis Care Res (Hoboken). 2018 Oct;70(10):1563-1567. doi: 10.1002/acr.23487. Epub 2018 Sep 4.

PMID:
29195024
20.

Work disability in gout: a population-based case-control study.

Sigurdardottir V, Drivelegka P, Svärd A, Jacobsson LTH, Dehlin M.

Ann Rheum Dis. 2018 Mar;77(3):399-404. doi: 10.1136/annrheumdis-2017-212063. Epub 2017 Nov 23.

PMID:
29170202
21.

Secular trends in sickness absence among Swedish patients with ankylosing spondylitis and psoriatic arthritis.

Nielsen C, Petersson IF, Jacobsson LTH, Jöud A.

Rheumatol Int. 2018 Feb;38(2):275-282. doi: 10.1007/s00296-017-3809-z. Epub 2017 Sep 6.

22.

Incidence of and risk factors for nephrolithiasis in patients with gout and the general population, a cohort study.

Landgren AJ, Jacobsson LTH, Lindström U, Sandström TZS, Drivelegka P, Björkman L, Fjellstedt E, Dehlin M.

Arthritis Res Ther. 2017 Jul 24;19(1):173. doi: 10.1186/s13075-017-1376-z.

23.

The yield of a positive MRI of the spine as imaging criterion in the ASAS classification criteria for axial spondyloarthritis: results from the SPACE and DESIR cohorts.

Ez-Zaitouni Z, Bakker PA, van Lunteren M, de Hooge M, van den Berg R, Reijnierse M, Fagerli KM, Landewé RB, Ramonda R, Jacobsson LT, Saraux A, Lenczner G, Feydy A, Pialat JB, Thévenin F, van Gaalen FA, van der Heijde D.

Ann Rheum Dis. 2017 Oct;76(10):1731-1736. doi: 10.1136/annrheumdis-2017-211486. Epub 2017 Jun 29.

PMID:
28663306
24.

Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.

Bengtsson K, Forsblad-d'Elia H, Lie E, Klingberg E, Dehlin M, Exarchou S, Lindström U, Askling J, Jacobsson LTH.

Arthritis Res Ther. 2017 May 18;19(1):102. doi: 10.1186/s13075-017-1315-z.

25.

Severe Extraarticular Manifestations in a Community-based Cohort of Patients with Rheumatoid Arthritis: Risk Factors and Incidence in Relation to Treatment with Tumor Necrosis Factor Inhibitors.

Theander L, Nyhäll-Wåhlin BM, Nilsson JÅ, Willim M, Jacobsson LTH, Petersson IF, Turesson C.

J Rheumatol. 2017 Jul;44(7):981-987. doi: 10.3899/jrheum.161103. Epub 2017 May 1.

PMID:
28461642
26.

The influence of discrepant imaging judgements on the classification of axial spondyloarthritis is limited: a replication in the SpondyloArthritis Caught Early (SPACE) cohort.

Ez-Zaitouni Z, van Lunteren M, Bakker PAC, van den Berg R, Reijnierse M, Fagerli KM, Landewé RBM, Ramonda R, Jacobsson LTH, van Gaalen FA, van der Heijde D.

Ann Rheum Dis. 2018 Jan;77(1):e1. doi: 10.1136/annrheumdis-2017-211553. Epub 2017 Apr 17. No abstract available.

PMID:
28416518
27.

Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register.

Lie E, Lindström U, Zverkova-Sandström T, Olsen IC, Forsblad-d'Elia H, Askling J, Kapetanovic MC, Kristensen LE, Jacobsson LTH.

Ann Rheum Dis. 2017 Sep;76(9):1515-1521. doi: 10.1136/annrheumdis-2016-210931. Epub 2017 Mar 2.

PMID:
28254789
28.

Societal costs and patients' experience of health inequities before and after diagnosis of psoriatic arthritis: a Danish cohort study.

Kristensen LE, Jørgensen TS, Christensen R, Gudbergsen H, Dreyer L, Ballegaard C, Jacobsson LTH, Strand V, Mease PJ, Kjellberg J.

Ann Rheum Dis. 2017 Sep;76(9):1495-1501. doi: 10.1136/annrheumdis-2016-210579. Epub 2017 Jan 30.

PMID:
28137915
29.

Factors associated with initiation and persistence of urate-lowering therapy.

Dehlin M, Ekström EH, Petzold M, Strömberg U, Telg G, Jacobsson LT.

Arthritis Res Ther. 2017 Jan 17;19(1):6. doi: 10.1186/s13075-016-1211-y.

30.

Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work?

Olofsson T, Petersson IF, Eriksson JK, Englund M, Nilsson JA, Geborek P, Jacobsson LTH, Askling J, Neovius M; ARTIS Study Group.

Ann Rheum Dis. 2017 Jul;76(7):1245-1252. doi: 10.1136/annrheumdis-2016-210239. Epub 2017 Jan 10.

PMID:
28073801
31.

Work disability in non-radiographic axial spondyloarthritis patients before and after start of anti-TNF therapy: a population-based regional cohort study from southern Sweden.

Wallman JK, Jöud A, Olofsson T, Jacobsson LTH, Bliddal H, Kristensen LE.

Rheumatology (Oxford). 2017 May 1;56(5):716-724. doi: 10.1093/rheumatology/kew473.

PMID:
28064208
32.

Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study.

Bengtsson K, Jacobsson LT, Rydberg B, Kvist G, Torstenson T, Dehlin M, Hilme E, Lindhé A, Wallerstedt SM, Forsblad-d'Elia H.

BMC Musculoskelet Disord. 2016 Dec 12;17(1):499.

33.

Incidence and prevalence of gout in Western Sweden.

Dehlin M, Drivelegka P, Sigurdardottir V, Svärd A, Jacobsson LT.

Arthritis Res Ther. 2016 Jul 13;18:164. doi: 10.1186/s13075-016-1062-6.

34.

Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers.

Hellgren K, Dreyer L, Arkema EV, Glintborg B, Jacobsson LT, Kristensen LE, Feltelius N, Hetland ML, Askling J; ARTIS Study Group, For the DANBIO Study Group.

Ann Rheum Dis. 2017 Jan;76(1):105-111. doi: 10.1136/annrheumdis-2016-209270. Epub 2016 May 4.

PMID:
27147709
35.

Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis.

Ljung L, Rantapää-Dahlqvist S, Jacobsson LT, Askling J.

Ann Rheum Dis. 2016 Dec;75(12):2087-2094. doi: 10.1136/annrheumdis-2015-208995. Epub 2016 Mar 16.

PMID:
26984007
36.

Back pain and health status in patients with clinically diagnosed ankylosing spondylitis, psoriatic arthritis and other spondyloarthritis: a cross-sectional population-based study.

Lindström U, Bremander A, Haglund E, Bergman S, Petersson IF, Jacobsson LT.

BMC Musculoskelet Disord. 2016 Feb 27;17:106. doi: 10.1186/s12891-016-0960-8.

37.

Pregnancy outcomes in patients with ankylosing spondylitis: a nationwide register study.

Jakobsson GL, Stephansson O, Askling J, Jacobsson LT.

Ann Rheum Dis. 2016 Oct;75(10):1838-42. doi: 10.1136/annrheumdis-2015-207992. Epub 2015 Dec 23.

PMID:
26698845
38.

Effectiveness and Feasibility Associated with Switching to a Second or Third TNF Inhibitor in Patients with Psoriatic Arthritis: A Cohort Study from Southern Sweden.

Kristensen LE, Lie E, Jacobsson LT, Christensen R, Mease PJ, Bliddal H, Geborek P.

J Rheumatol. 2016 Jan;43(1):81-7. doi: 10.3899/jrheum.150744. Epub 2015 Dec 1.

PMID:
26628604
39.

High serum cholesterol predicts rheumatoid arthritis in women, but not in men: a prospective study.

Turesson C, Bergström U, Pikwer M, Nilsson JÅ, Jacobsson LT.

Arthritis Res Ther. 2015 Oct 12;17:284. doi: 10.1186/s13075-015-0804-1.

40.

Surgical interventions for nephrolithiasis in ankylosing spondylitis and the general population.

Jakobsen AK, Jacobsson LTH, Patschan O, Hopfgarten T, Askling J, Kristensen LE.

Scand J Urol. 2015 Dec;49(6):486-491. doi: 10.3109/21681805.2015.1089523. Epub 2015 Sep 21.

PMID:
26389795
41.

A high body mass index is associated with reduced risk of rheumatoid arthritis in men, but not in women.

Turesson C, Bergström U, Pikwer M, Nilsson JÅ, Jacobsson LT.

Rheumatology (Oxford). 2016 Feb;55(2):307-14. doi: 10.1093/rheumatology/kev313. Epub 2015 Sep 8.

PMID:
26350488
42.

Mortality in ankylosing spondylitis: results from a nationwide population-based study.

Exarchou S, Lie E, Lindström U, Askling J, Forsblad-d'Elia H, Turesson C, Kristensen LE, Jacobsson LT.

Ann Rheum Dis. 2016 Aug;75(8):1466-72. doi: 10.1136/annrheumdis-2015-207688. Epub 2015 Sep 2.

PMID:
26338036
43.

The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study.

Exarchou S, Lindström U, Askling J, Eriksson JK, Forsblad-d'Elia H, Neovius M, Turesson C, Kristensen LE, Jacobsson LT.

Arthritis Res Ther. 2015 May 9;17:118. doi: 10.1186/s13075-015-0627-0.

44.

The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.

Lie E, Kristensen LE, Forsblad-d'Elia H, Zverkova-Sandström T, Askling J, Jacobsson LT; ARTIS Study Group.

Ann Rheum Dis. 2015 Jun;74(6):970-8. doi: 10.1136/annrheumdis-2014-206616. Epub 2015 Feb 20.

PMID:
25710471
45.

Safety of Etoricoxib, Celecoxib, and Nonselective Nonsteroidal Antiinflammatory Drugs in Ankylosing Spondylitis and Other Spondyloarthritis Patients: A Swedish National Population-Based Cohort Study.

Kristensen LE, Jakobsen AK, Askling J, Nilsson F, Jacobsson LT.

Arthritis Care Res (Hoboken). 2015 Aug;67(8):1137-49. doi: 10.1002/acr.22555.

46.

MRI assessment of early response to certolizumab pegol in rheumatoid arthritis: a randomised, double-blind, placebo-controlled phase IIIb study applying MRI at weeks 0, 1, 2, 4, 8 and 16.

Østergaard M, Jacobsson LT, Schaufelberger C, Hansen MS, Bijlsma JW, Dudek A, Rell-Bakalarska M, Staelens F, Haake R, Sundman-Engberg B, Bliddal H.

Ann Rheum Dis. 2015 Jun;74(6):1156-63. doi: 10.1136/annrheumdis-2014-206359. Epub 2014 Dec 15.

47.

Drug adherence, response and predictors thereof for tocilizumab in patients with rheumatoid arthritis: results from the Swedish biologics register.

Forsblad-d'Elia H, Bengtsson K, Kristensen LE, Jacobsson LT.

Rheumatology (Oxford). 2015 Jul;54(7):1186-93. doi: 10.1093/rheumatology/keu455. Epub 2014 Dec 13.

PMID:
25505001
48.

Is nephrolithiasis an unrecognized extra-articular manifestation in ankylosing spondylitis? A prospective population-based Swedish national cohort study with matched general population comparator subjects.

Jakobsen AK, Jacobsson LT, Patschan O, Askling J, Kristensen LE.

PLoS One. 2014 Nov 25;9(11):e113602. doi: 10.1371/journal.pone.0113602. eCollection 2014.

49.

Quality of Life in Patients With Axial Spondyloarthritis in Clinical Practice In Sweden: Baseline Results From A Longitudinal Study.

Jacobsson LT, Husmark T, Theander E, Henriksson K, Johansson M, Büsch K.

Value Health. 2014 Nov;17(7):A386. doi: 10.1016/j.jval.2014.08.2648. Epub 2014 Oct 26. No abstract available.

50.

Effects of adalimumab treatment on endothelial cell activation markers in the skeletal muscle of patients with rheumatoid arthritis.

Bergström U, Grundtman C, Lundberg IE, Jacobsson LT, Nilsson K, Turesson C.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):883-90. Epub 2014 Oct 2.

PMID:
25287961

Supplemental Content

Loading ...
Support Center